Table 1.
Patient demographics, hormone, and chemokine results for obese and non-obese patients with endometrial and ovarian cancer.
| Demographic or Result of Patients from UNC CSC | BMI Obese (n=33)Non-obese (n=28) | All Patients(n=61) | Patients with Endometrial Cancer(n=39) | Patients with Ovarian Cancer(n=22) |
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | ||
| BMI (kg/m2) | Obese | 41.5 ± 7.2 | 46.2 ± 4.6 | 34.3 ± 3.6 |
| Non-obese | 22.7 ± 1.7 | 22.5 ± 2.0 | 23.1 ± 0.7 | |
| TBW (kg) | Obese | 110.2 ± 22.2 | 122.7 ± 17.8 | 91.0 ± 12.3 |
| Non-obese | 59.3 ± 6.7 | 58.1 ± 7.4 | 61.8 ± 3.9 | |
| BSA (m2) | Obese | 2.12 ± 0.2 | 2.22 ± 0.2 | 1.96 ± 0.2 |
| Non-obese | 1.62 ± 0.1 | 1.60 ± 0.1 | 1.67 ± 0.1 | |
| Estradiol (pg/mL) | Obese | 110.0 ± 73.2 | 126.6 ± 82.0 | 84.6 ± 50.0 |
| Non-obese | 61.7 ± 50.6 | 59.8 ± 47.7 | 65.9 ± 56.0 | |
| Estrone (pg/mL) | Obese | 73.1 ± 28.1 | 75.9 ± 30.4 | 68.6 ± 24.6 |
| Non-obese | 62.1 ± 20.7 | 59.5 ± 19.3 | 68.1 ± 22.5 | |
| Testosterone (pg/mL) | Obese | 4.8 ± 17.0 | 7.05 ± 21.7 | 1.2 ± 0.7 |
| Non-obese | 1.3 ± 1.3 | 1.3 ± 1.4 | 1.1 ± 0.9 | |
| 5-DHT (pg/mL) | Obese | 205.7 ± 141.2 | 237.6 ± 164.7 | 156.7 ± 76.9 |
| Non-obese | 147.0 ± 86.2 | 151.8 ± 92.3 | 136.3 ± 70.6 | |
| CCL2 (pg/mL) | Obese | 178.9 ± 84.4 | 153.9 ± 46.7 | 217.5 ± 113.5 |
| Non-obese | 174.1 ± 86.2 | 140.7 ± 69.7 | 248.4 ± 218.97 | |
| CCL5 (pg/mL) | Obese | 16,313.8 ± 14931.3 | 13,867.8 ± 14,137.6 | 19,770.4 ± 22,206.6 |
| Non-obese | 19,703.3 ± 25,396.7 | 19,673.2 ± 27,255.8 | 20,076.9 ± 15,897.7 |